Bone Marrow Mesenchymal Stem Cells Ameliorate Diabetes and Diabetic Renal Fibrosis by Modulating the Inflammatory Factor IL-11
MSC therapy improves nephropathy, likely by inhibiting IL-11 and reducing fibrosis- related markers, making it a promising treatment for DN.
Authors
- Yi-Hua Bai (ORCID: https://orcid.org/0000-0003-0739-4594)
- Hongying Jiang (ORCID: https://orcid.org/0000-0002-2581-0646)
- Yayi Hou (ORCID: https://orcid.org/0000-0002-1152-9132)
- Ji Yang
- Lilan Huang (ORCID: https://orcid.org/0009-0007-6295-5215)
Institutions
- Kunming Medical University (CN)
Publication Details
- Journal
- Current Stem Cell Research & Therapy
- Published
- 2024-12-30
- DOI
- https://doi.org/10.2174/011574888x348254241216171655
- Citations
- 3
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.02